Does Preoperative Transarterial Chemoembolization for Hepatocellular Carcinoma Increase the Incidence of Hepatic Artery Thrombosis After Living-Donor Liver Transplant?


İNCE V. , ERSAN V. , KARAKAŞ S. , KUTLUTÜRK K. , KARADAĞ SOYLU N. , KUTLU R. , ...Daha Fazla

EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.15, ss.21-24, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 15
  • Basım Tarihi: 2017
  • Doi Numarası: 10.6002/ect.tond16.l7
  • Dergi Adı: EXPERIMENTAL AND CLINICAL TRANSPLANTATION
  • Sayfa Sayıları: ss.21-24

Özet

Objectives: Transarterial chemoembolization is a potential risk factor for hepatic artery damage, which may lead to severe consequences. We aimed to investigate this controversial issue in our population of liver transplant patients with hepatocellular carcinoma.